RHELIXA
Rhelixa is a leader in epigenome analysis.We analyze genomes, epigenomes, and transcriptomes using our proprietary technologies to dramatically improve the efficiency and accuracy of R & D.
RHELIXA
Social Links:
Industry:
Analytics Big Data Biotechnology Health Care
Founded:
2015-02-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.rhelixa.com
Total Employee:
11+
Status:
Active
Contact:
03-6240-9330
Email Addresses:
[email protected]
Total Funding:
2.2 M USD
Technology used in webpage:
Mobile Non Scaleable Content Euro Amazon JsDelivr Google BootstrapCDN Google Cloud JQuery CDN Amazon S3 Ubuntu
Similar Organizations
Amwise Diagnostic
Amwise Diagnostic is a leader in precision medicine technology for cancer.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sompo Japan Nipponkoa Insurance
Sompo Japan Nipponkoa Insurance investment in Corporate Round - Rhelixa
Mitsubishi Corporation
Mitsubishi Corporation investment in Corporate Round - Rhelixa
Leave a Nest
Leave a Nest investment in Corporate Round - Rhelixa
UT Research Institute
UT Research Institute investment in Seed Round - Rhelixa
SIOS Technology Corp.
SIOS Technology Corp. investment in Seed Round - Rhelixa
Capital Medica Ventures
Capital Medica Ventures investment in Seed Round - Rhelixa
Leave a Nest
Leave a Nest investment in Pre Seed Round - Rhelixa
Official Site Inspections
http://www.rhelixa.com
- Host name: sv1426.xserver.jp
- IP address: 183.90.253.27
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "Rhelixa"
株式会社Rhelixa（レリクサ）
老いを恐れない社会の実現に向け、株式会社Rhelixa（レリクサ）総額4.9億円の資金調達を実施See details»
SERVICE - 株式会社Rhelixa（レリクサ）
Rhelixaに参画後、IPOを見据えた社内制度改革や基盤整備を実施。 東京大学大学院農学生命科学研究科 博士課程修了、博士（農学）。 2002年大学院在学中に理工系大学生・大学院生のみでリバネスを設立。 日本初「科学出前実験教 …See details»
COMPANY PROFILE - 株式会社Rhelixa（レリクサ）
Ryo specializes in the analysis of large-scale omics data, especially epigenomic analysis. Ryo is a councilor of the Japanese Society of Anti-Aging Medicine. After graduating from Yokohama National University, Tomoyuki joined Mitsubishi …See details»
Rhelixa - Crunchbase Company Profile & Funding
Rhelixa is a biotechnology company that provides various advanced genomic and epigenomic research services. View contacts for Rhelixa to access new leads and connect with decision …See details»
The KIRIN HEALTH INNOVATION FUND Invests In …
TOKYO, August 23, 2024 – Kirin Holdings Company, Limited (Kirin Holdings) announced today that it has invested in Rhelixa, Inc. …See details»
RHELIXA, INC. Company Profile | CHUO-KU, TOKYO, Japan
Find company research, competitor information, contact details & financial data for RHELIXA, INC. of CHUO-KU, TOKYO. Get the latest business insights from Dun & Bradstreet.See details»
Rhelixa - Products, Competitors, Financials, Employees, …
Global Brain has invested in Rhelixa, Inc. (Rhelixa), a leading company in epigenome analysis, through its KIRIN HEALTH INNOVATION FUND. Rhelixa is a startup from the University of …See details»
Rhelixa Company Profile - Office Locations, Competitors ... - Craft
Rhelixa (レリクサ) is a company specializing in the epigenomic analysis. It is engaged in the analysis of genomes, epigenomes, and transcriptomes using biotech and machine learning …See details»
エピゲノム情報の解析を手掛けるRhelixaとの資本業務提携契約締 …
Nov 26, 2018 · 三菱商事株式会社（代表取締役社長：垣内威彦、以下「当社」）は、株式会社Rhelixa（代表取締役社長：仲木竜、以下「レリクサ」）が行う第三者割当増資を1.35億円 …See details»
KIRIN HEALTH INNOVATION FUND invests in epigenome analysis …
TOKYO, August 23, 2024 – Kirin Holdings Company, Limited (Kirin Holdings) announced today that it has invested in Rhelixa, Inc. (https://www.rhelixa.com/) (Rhelixa) through the KIRIN …See details»
Decoding Life, Creating Future. - 株式会社Rhelixa（レリクサ）
Rhelixa is a leading company in epigenomic analysis. We analyze omics data such as genomic, epigenomic, transcriptomic, and metagenomic information by professional scientific consulting, …See details»
Rhelixa - Funding, Financials, Valuation & Investors - Crunchbase
Rhelixa is a biotechnology company that provides various advanced genomic and epigenomic research services.See details»
老いを恐れない社会の実現に向け、株式会社Rhelixa（レリクサ）
Aug 20, 2024 · エピクロック®事業は、独自の生物学的年齢評価技術*1を起点として、生活習慣の改善や特定の介入がもたらす抗老化効果を評価する研究支援、企業・研究機関との連携を …See details»
Rhelixa - Contacts, Employees, Board Members, Advisors & Alumni
Rhelixa is a biotechnology company that provides various advanced genomic and epigenomic research services.See details»
Leave a Nest Capital Makes Additional Investment in Rhelixa, Inc.
Aug 20, 2024 · Leave a Nest Group has invested in Rhelixa, Inc. (Head office: Tokyo, Japan; Representative Director, CEO/CTO: Ryo Nakaki; hereinafter “Rhelixa”), through Leave a Nest …See details»
Mitsubishi Corporation Announces Capital Alliance with Rhelixa …
Nov 26, 2018 · Mitsubishi Corporation (MC) is pleased to announce that it has entered into a capital alliance agreement with Rhelixa Co., Ltd. for 135 million yen via the acceptance of third …See details»
STRENGTH | 株式会社Rhelixa（レリクサ）
Our company has many researchers on staff, including M.D.s and Ph.D.s. Researchers with a track record of leading large-scale projects in clinical and basic research using omics analysis …See details»
Rhelixa Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Rhelixa. Use the PitchBook Platform to explore the full profile.See details»
Ryu Nakagi - CEO @ Rhelixa - Crunchbase Person Profile
Specializes in the development and application of specialized analysis algorithms for large-scale genomic and epigenomic data obtained from next-generation sequencers. Established Rhelixa …See details»
Global Brain has invested in Rhelixa, Inc., a leading company in ...
Global Brain has invested in Rhelixa, Inc. (Rhelixa), a leading company in epigenome analysis, through its KIRIN HEALTH INNOVATION FUND. Rhelixa is a startup from the University of …See details»